| Filed 2021-08-18 14:20 Tx date 2021-08-18 | $GUD
Knight Therapeutics Inc. | Lande, Robert Nathaniel 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $109,800
+20,000 vol
$5.49 each | 85,714 | |
| Filed 2021-08-18 14:16 Tx date 2021-08-18 | $GUD
Knight Therapeutics Inc. | Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Dana Caplan (Indirect Ownership) | Common Shares 10 - Acquisition or disposition in the public market | $8,084
+1,500 vol
$5.39 each | 1,500 | |
| Filed 2021-08-18 14:15 Tx date 2014-02-28 | $GUD
Knight Therapeutics Inc. | Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Holder: Dana Caplan (Indirect Ownership) | Common Shares 00 - Opening Balance-Initial SEDI Report | | | |
| Filed 2021-08-18 14:13 Tx date 2021-08-18 | $GUD
Knight Therapeutics Inc. | Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $97,200
+18,000 vol
$5.40 each | 627,488 | |
| Filed 2021-08-18 14:12 Tx date 2021-08-18 | $GUD
Knight Therapeutics Inc. | Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $97,020
+18,000 vol
$5.39 each | 609,488 |